{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:05:11Z","timestamp":1759536311490,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ajkd.2001.27425","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T23:33:20Z","timestamp":1205796800000},"page":"S147-S151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S","title":["Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients"],"prefix":"10.1053","volume":"38","author":[{"given":"Tadao","family":"Akizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2001","series-title":"An Overview of Regular Dialysis Treatment in Japan as of December 31, 2000","author":"Japanese Society for Dialysis Therapy","key":"10.1053\/ajkd.2001.27425_BIB1"},{"key":"10.1053\/ajkd.2001.27425_BIB2","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1248\/cpb.40.1494","article-title":"Synthetic studies of vitamin D analogues. XI. Synthesis and differentiation-inducing activity of 1\u03b1, 25-dihydroxy-22-oxavitamin D3 analogues","volume":"40","author":"Kubodera","year":"1992","journal-title":"Chem Pharm Bull"},{"key":"10.1053\/ajkd.2001.27425_BIB3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3177\/jnsv.36.21","article-title":"Prevention of immunological disorder in MRL\/1 mice by a new synthetic analogue of vitamin D3: 22-oxa-1\u03b1, 25-dihydroxyvitamin D3","volume":"36","author":"Abe","year":"1990","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1053\/ajkd.2001.27425_BIB4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","article-title":"The noncalcemic analogue of vitamin D, 22-oxacalcitriol suppresses parathyroid hormone synthesis and secretion","volume":"84","author":"Brown","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2001.27425_BIB5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.1991.110","article-title":"Regulation of parathyroid hormone synthesis in chronic renal failure in rats","volume":"39","author":"Fukagawa","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27425_BIB6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ki.1993.280","article-title":"Effect of 22-oxa-calcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism","volume":"44","author":"Kubrusly","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27425_BIB7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.1996.283","article-title":"1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats","volume":"50","author":"Denda","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27425_BIB8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1440-1797.1998.tb00377.x","article-title":"Attenuated up-regulation of vitamin D-dependent calcium-binding proteins by 22-oxa-1, 25-dihydroxyvitamin D3 in uremic rats. A possible mechanism for less-calcemic action","volume":"4","author":"Ichikawa","year":"1998","journal-title":"Nephrology"},{"key":"10.1053\/ajkd.2001.27425_BIB9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1128\/MCB.19.2.1049","article-title":"Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog","volume":"19","author":"Takeyama","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1053\/ajkd.2001.27425_BIB10","first-page":"715","article-title":"Effect of 22-oxacalcitriol injection for treatment of secondary hyperparathyroidism in renal insufficiency patients undergoing dialysis [Japanese]","volume":"47","author":"Kurokawa","year":"1999","journal-title":"Kidney Dial"},{"key":"10.1053\/ajkd.2001.27425_BIB11","first-page":"1810A","article-title":"Suppressive effect of 22-oxacalcitriol on secondary hyperparathyroidism of hemodialysis patients. A double blind comparison among four doses","volume":"7","author":"Akizawa","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2001.27425_BIB12","first-page":"243","article-title":"Effect of long-term administration of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patients [Japanese]","volume":"48","author":"Kurokawa","year":"2000","journal-title":"Kidney Dial"},{"key":"10.1053\/ajkd.2001.27425_BIB13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(00)70198-3","article-title":"Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism","volume":"35","author":"Tsukamoto","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2001.27425_BIB14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1523-1755.1999.055003821.x","article-title":"22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure","volume":"55","author":"Monier-Faugere","year":"1999","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860183643X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860183643X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:23:11Z","timestamp":1759454591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860183643X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S027263860183643X"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2001.27425","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2001.27425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}